Medication adherence in the 12-month follow-up period after the Support, Educate, Empower (SEE) glaucoma coaching program

Document Type

Conference Proceeding

Publication Date

6-1-2022

Publication Title

Invest Ophthalmol Vis Sci

Abstract

Purpose : Motivational Interviewing (MI) has improved medication adherence rates for patients with chronic illnesses. The Support, Educate, Empower (SEE) program, a 7-month MI-based personalized glaucoma coaching program, has previously shown to improve medication adherence by 21-percentage points in a sample of non-adherent glaucoma patients. The goal of this study was to assess adherence in the 12-months following the conclusion of the SEE program intervention. Methods : Glaucoma patients ≥40 years, taking ≥1 medication, self-reporting poor medication adherence were recruited from the University of Michigan for the SEE pilot study. Participants' medication adherence rates were monitored electronically (AdhereTech, New York, NY) during a 3-month pre-intervention phase (pre-counselling adherence), 7-month intervention phase while they received personalized coaching sessions (counselling adherence), and for an additional 12-months following the conclusion of their coaching sessions (post-counselling adherence). Adherence was summarized with descriptive statistics and compared using paired t-tests. Results : Medication adherence data were available for 39 participants. Post-counselling adherence rates were censored for 18 participants (56%); 3 participants received glaucoma laser or incisional surgery, 3 had changes made to their glaucoma medication regiment, and 12 stopped using their electronic medication monitors before the full 12- month follow-up period. Average follow-up was 284 days (standard deviation, SD=110, range=41 to 365). The average post-counselling adherence was 66.5% (SD=22.5%), significantly less than the average counselling adherence rate of 81.3% (SD=17.6%, p<0.0001) but significantly more than pre-counselling adherence rate of 59.9% (SD=18.5%, p=0.04). The decrease in adherence post-counseling was mostly observed in the first 4 months (mean decrease=17.4%, SD=19.5%, p<0.0001). Conclusions : Medication adherence rates significantly decreased among SEE program participants in the 12 months following their last counselling session, although they were still significantly higher than pre-counselling adherence rates. These results suggest that glaucoma patients may need additional counselling sessions to see continued benefit from the program. We suggest that patients should be seen every 3-month for a ?booster? counselling session.

Volume

63

Issue

7

First Page

1646-A0141

Find It @ Sladen

Share

COinS